Dose escalation with overdose control using a quasi-continuous toxicity score in cancer Phase I clinical trials-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Dose escalation with overdose control using a quasi-continuous toxicity score in cancer Phase I clinical trials

Published:2012-09 Issue:5 Volume:33 Page:949-958
ISSN:1551-7144
Container-title:Contemporary Clinical Trials
language:en
Short-container-title:Contemporary Clinical Trials

Author:

Chen Zhengjia,Tighiouart Mourad,Kowalski Jeanne

Funder

NIH/NCI

CTSI Grant

National Center for Research Resources

National Center for Advancing Translational Sciences

Publisher

Elsevier BV

Subject

Pharmacology (medical),General Medicine

Reference27 articles.

1. A Phase I/II trial combining high-dose melphalan and autologous transplant with bortezomib for multiple myeloma: a dose- and schedule-finding study;Lonial;Clin Cancer Res,2010

2. A phase 1 dose escalation study of bortezomib combined with rituximab, cyclophosphamide, doxorubicin, modified vincristine, and prednisone for untreated follicular lymphoma and other low-grade B-cell lymphomas;Sinha;Cancer,2012

3. Phase I dose escalation, pharmacokinetic and pharmacodynamic study of naptumomab estafenatox alone in patients with advanced cancer and with docetaxel in patients with advanced non-small-cell lung cancer;Borghaei;J Clin Oncol,2009

4. Individualized patient dosing in phase I clinical trials: the role of EWOC in PNU-214936;Cheng;J Clin Oncol,2004

5. Phase I. studies of chemotherapeutic agents in cancer patients: a review of the designs;Potter;J Biopharm Stat,2006

Cited by 31 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Dose Finding in Oncology Trials Guided by Ordinal Toxicity Grades Using Continuous Dose Levels;Entropy;2024-08-14

2. A Bayesian quasi-likelihood design for identifying the minimum effective dose and maximum utility dose in dose-ranging studies;Statistical Methods in Medical Research;2024-04-04

3. Bayesian dose escalation with overdose and underdose control utilizing all toxicities in Phase I/II clinical trials;Biometrical Journal;2023-12-04

4. A flexible dose-response modeling framework based on continuous toxicity outcomes in phase I cancer clinical trials;Trials;2023-11-21

5. qTPI: A quasi-toxicity probability interval design for phase I trials with multiple-grade toxicities;Statistical Methods in Medical Research;2023-06-06

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3